Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
Clinical guideline published by American Society of Clinical Oncology (ASCO) on
The American Society of Clinical Oncology (ASCO) is a leading organization dedicated to advancing cancer care through research, education, and clinical practice. ASCO provides evidence-based clinical guidelines to support oncologists in delivering optimal patient care and improving outcomes.